Find Carvedilol Phosphate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0 DRUGS IN DEVELOPMENT

FDF DossiersDRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

226 RELATED EXCIPIENT COMPANIES

381EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Carvedilol phosphate, 1196658-85-1, Carvedilol (phosphate hemihydrate), 4s19o2f64l, Bm 14190 (phosphate hemihydrate), 2-propanol, 1-(9h-carbazol-4-yloxy)-3-((2-(2-methoxyphenoxy)ethyl)amino)-, phosphate, hydrate (1:1:1)
Molecular Formula
C24H31N2O9P
Molecular Weight
522.5  g/mol
InChI Key
JAYBFQXVKDGMFT-UHFFFAOYSA-N
FDA UNII
4S19O2F64L

Carvedilol Phosphate
Carvedilol Phosphate is the phosphate salt form of carvedilol, a racemic mixture and adrenergic blocking agent with antihypertensive activity and devoid of intrinsic sympathomimetic activity. The S enantiomer of carvedilol nonselectively binds to and blocks beta-adrenergic receptors, thereby exerting negative inotropic and chronotropic effects, and leading to a reduction in cardiac output. In addition, both enantiomers of carvedilol bind to and block alpha 1-adrenergic receptors, thereby causing vasodilation and reducing peripheral vascular resistance.
1 2D Structure

Carvedilol Phosphate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol;phosphoric acid;hydrate
2.1.2 InChI
InChI=1S/C24H26N2O4.H3O4P.H2O/c1-28-21-10-4-5-11-22(21)29-14-13-25-15-17(27)16-30-23-12-6-9-20-24(23)18-7-2-3-8-19(18)26-20;1-5(2,3)4;/h2-12,17,25-27H,13-16H2,1H3;(H3,1,2,3,4);1H2
2.1.3 InChI Key
JAYBFQXVKDGMFT-UHFFFAOYSA-N
2.1.4 Canonical SMILES
COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O.O.OP(=O)(O)O
2.2 Other Identifiers
2.2.1 UNII
4S19O2F64L
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Carvedilol Phosphate

2. 1196658-85-1

3. Carvedilol (phosphate Hemihydrate)

4. 4s19o2f64l

5. Bm 14190 (phosphate Hemihydrate)

6. 2-propanol, 1-(9h-carbazol-4-yloxy)-3-((2-(2-methoxyphenoxy)ethyl)amino)-, Phosphate, Hydrate (1:1:1)

7. 2-propanol,1-(9h-carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-,phosphate (salt), Hydrate (2:2:1)

8. Unii-4s19o2f64l

9. Schembl599530

10. 309c892

11. Q27260413

12. 1-9h-(carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-2-propanol Phosphate Hemihydrate

2.4 Create Date
2008-01-22
3 Chemical and Physical Properties
Molecular Weight 522.5 g/mol
Molecular Formula C24H31N2O9P
Hydrogen Bond Donor Count7
Hydrogen Bond Acceptor Count10
Rotatable Bond Count10
Exact Mass522.17671757 g/mol
Monoisotopic Mass522.17671757 g/mol
Topological Polar Surface Area155 Ų
Heavy Atom Count36
Formal Charge0
Complexity557
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count3
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameCoreg cr
PubMed HealthCarvedilol (By mouth)
Drug ClassesAntianginal, Antihypertensive, Cardiovascular Agent
Active IngredientCarvedilol phosphate
Dosage FormCapsule, extended release
RouteOral
Strength10mg; 80mg; 40mg; 20mg
Market StatusPrescription
CompanySb Pharmco

2 of 2  
Drug NameCoreg cr
PubMed HealthCarvedilol (By mouth)
Drug ClassesAntianginal, Antihypertensive, Cardiovascular Agent
Active IngredientCarvedilol phosphate
Dosage FormCapsule, extended release
RouteOral
Strength10mg; 80mg; 40mg; 20mg
Market StatusPrescription
CompanySb Pharmco

5 Pharmacology and Biochemistry
5.1 FDA Pharmacological Classification
5.1.1 Pharmacological Classes
Adrenergic beta1-Antagonists [MoA]; Adrenergic beta2-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]; beta-Adrenergic Blocker [EPC]; Adrenergic alpha-Antagonists [MoA]

API Reference Price

read-more
read-more
[{"dataSource":"API Import","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1636655400,"product":"CARVEDILOL PHOSPHATE HEMIHYDRATE","address":"PLOT NO.2, MAITRIVIHAR BEHIND MAITRIVANAM, AMEERPET","city":"HYDERABAD","supplier":"POLPHARMA","supplierCountry":"POLAND","foreign_port":"NA","customer":"AUROBINDO PHARMA LIMITED","customerCountry":"INDIA","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"6850","totalValueFC":"6949.2","currency":"USD","unitRateINR":"517517.5","date":"12-Nov-2021","totalValueINR":"517517.5","totalValueInUsd":"6949.2","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"6226864","productDescription":"API","marketType":"REGULATED MARKET","country":"POLAND","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"PLOT NO.2, MAITRIVIHAR BEHIND MAITRIVANAM, AMEERPET"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1656959400,"product":"CARVEDILOL PHOSPHATE HEMIHYDRATE","address":"PLOT NO.2, MAITRIVIHAR BEHIND MAITRIVANAM, AMEERPET","city":"HYDERABAD","supplier":"ZHEJIANG HUAHAI PHARMACEUTICAL","supplierCountry":"CHINA","foreign_port":"NA","customer":"AUROBINDO PHARMA LIMITED","customerCountry":"INDIA","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"2800","totalValueFC":"2780.1","currency":"USD","unitRateINR":"221060","date":"05-Jul-2022","totalValueINR":"221060","totalValueInUsd":"2780.1","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"9420018","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"PLOT NO.2, MAITRIVIHAR BEHIND MAITRIVANAM, AMEERPET"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1689532200,"product":"CARVEDILOL PHOSPHATE HEMIHYDRATE, BATCH NO. 101012328, QTY 6KG","address":"SPARC TANDALJA","city":"VADODARA","supplier":"SUN PHARMACEUTICAL INDUSTRIES LIMITED","supplierCountry":"NETHERLANDS","foreign_port":"NA","customer":"SUN PHARMACEUTICAL INDUSTRIES LIMITED","customerCountry":"INDIA","quantity":"6.00","actualQuantity":"6","unit":"KGS","unitRateFc":"5000","totalValueFC":"35264.2","currency":"USD","unitRateINR":"483058.4","date":"17-Jul-2023","totalValueINR":"2898349.363","totalValueInUsd":"35264.2","indian_port":"DELHI AIR","hs_no":"29339990","bill_no":"0","productDescription":"API","marketType":"REGULATED MARKET","country":"NETHERLANDS","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"SPARC TANDALJA"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1692815400,"product":"CARVEDILOL PHOSPHATE, BATCH NO:521300522-521300622-521300222-521300522","address":"901-911 9TH FLR ISCON ELEGANCE NR, SHAPATH 5 S G HIGHWAY","city":"AHMEDABAD","supplier":"TAPI TECHNOLOGY & API SERVICES","supplierCountry":"ISRAEL","foreign_port":"NA","customer":"AMNEAL PHARMACEUTICALS","customerCountry":"INDIA","quantity":"146.10","actualQuantity":"146.1","unit":"KGS","unitRateFc":"2000","totalValueFC":"295892.9","currency":"USD","unitRateINR":"166088.8","date":"24-Aug-2023","totalValueINR":"24510676.88","totalValueInUsd":"295892.9","indian_port":"AHEMDABAD AIR","hs_no":"29339990","bill_no":"0","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ISRAEL","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"901-911 9TH FLR ISCON ELEGANCE NR, SHAPATH 5 S G HIGHWAY"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1721327400,"product":"CARVEDILOL PHOSPHATE HEMIHYDRATE","address":"304,ATLANTA ARCADE,","city":"MUMBAI MAHARASHTRA","supplier":"POLPHARMA","supplierCountry":"POLAND","foreign_port":"WARSAW","customer":"MACLEODS PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"5000","totalValueFC":"5051.4","currency":"USD","unitRateINR":"422250","date":"19-Jul-2024","totalValueINR":"422250","totalValueInUsd":"5051.4","indian_port":"Bombay Air","hs_no":"29420090","bill_no":"4597170","productDescription":"API","marketType":"REGULATED MARKET","country":"POLAND","selfForZScoreResived":"Pharma Grade","supplierPort":"WARSAW","supplierAddress":"A. UL. PEPLINSKA 1983-200 STAROGARD GDANSKIPOLAND POLAND","customerAddress":"304,ATLANTA ARCADE,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1733423400,"product":"CARVEDILOL PHOSPHATE CARVEDILOL PHOSPHATE","address":"882\/1-871, NEAR KANKAVATI ,VILLAGE-","city":"AHMEDABAD, GUJARAT","supplier":"TAPI TECHNOLOGY & API SERVICES","supplierCountry":"ISRAEL","foreign_port":"TEL AVIV YAFO","customer":"AMNEAL PHARMACEUTICALS","customerCountry":"INDIA","quantity":"40.00","actualQuantity":"40","unit":"KGS","unitRateFc":"2200","totalValueFC":"88705.3","currency":"USD","unitRateINR":"188430","date":"06-Dec-2024","totalValueINR":"7537200","totalValueInUsd":"88705.3","indian_port":"Ahmedabad Air","hs_no":"29339990","bill_no":"7083387","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ISRAEL","selfForZScoreResived":"Pharma Grade","supplierPort":"TEL AVIV YAFO","supplierAddress":"PIET HEINKADE 107 1019 GM AMSTERDAM THE NETHERLANDS SDNF NL","customerAddress":"882\/1-871, NEAR KANKAVATI ,VILLAGE-"}]
12-Nov-2021
06-Dec-2024
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 10M...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 10MG

USFDA APPLICATION NUMBER - 22012

read-more

DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 20M...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 20MG

USFDA APPLICATION NUMBER - 22012

read-more

DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 40M...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 40MG

USFDA APPLICATION NUMBER - 22012

read-more

DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 80M...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 80MG

USFDA APPLICATION NUMBER - 22012

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Coating Systems & Additives

read-more
read-more

Fillers, Diluents & Binders

read-more
read-more

Controlled & Modified Release

read-more
read-more

Direct Compression

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Granulation

read-more
read-more

Solubilizers

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Lubricants & Glidants

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Co-Processed Excipients

read-more
read-more

Topical

read-more
read-more

Empty Capsules

read-more
read-more

Emulsifying Agents

read-more
read-more

Taste Masking

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Parenteral

read-more
read-more

Coloring Agents

read-more
read-more

Vegetarian Capsules

read-more
read-more

API Stability Enhancers

read-more
read-more

Rheology Modifiers

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Carvedilol Phosphate Hemihydrate Manufacturers

A Carvedilol Phosphate Hemihydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Carvedilol Phosphate Hemihydrate, including repackagers and relabelers. The FDA regulates Carvedilol Phosphate Hemihydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Carvedilol Phosphate Hemihydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Carvedilol Phosphate Hemihydrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Carvedilol Phosphate Hemihydrate Suppliers

A Carvedilol Phosphate Hemihydrate supplier is an individual or a company that provides Carvedilol Phosphate Hemihydrate active pharmaceutical ingredient (API) or Carvedilol Phosphate Hemihydrate finished formulations upon request. The Carvedilol Phosphate Hemihydrate suppliers may include Carvedilol Phosphate Hemihydrate API manufacturers, exporters, distributors and traders.

click here to find a list of Carvedilol Phosphate Hemihydrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Carvedilol Phosphate Hemihydrate USDMF

A Carvedilol Phosphate Hemihydrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Carvedilol Phosphate Hemihydrate active pharmaceutical ingredient (API) in detail. Different forms of Carvedilol Phosphate Hemihydrate DMFs exist exist since differing nations have different regulations, such as Carvedilol Phosphate Hemihydrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Carvedilol Phosphate Hemihydrate DMF submitted to regulatory agencies in the US is known as a USDMF. Carvedilol Phosphate Hemihydrate USDMF includes data on Carvedilol Phosphate Hemihydrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Carvedilol Phosphate Hemihydrate USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Carvedilol Phosphate Hemihydrate suppliers with USDMF on PharmaCompass.

Carvedilol Phosphate Hemihydrate WC

A Carvedilol Phosphate Hemihydrate written confirmation (Carvedilol Phosphate Hemihydrate WC) is an official document issued by a regulatory agency to a Carvedilol Phosphate Hemihydrate manufacturer, verifying that the manufacturing facility of a Carvedilol Phosphate Hemihydrate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Carvedilol Phosphate Hemihydrate APIs or Carvedilol Phosphate Hemihydrate finished pharmaceutical products to another nation, regulatory agencies frequently require a Carvedilol Phosphate Hemihydrate WC (written confirmation) as part of the regulatory process.

click here to find a list of Carvedilol Phosphate Hemihydrate suppliers with Written Confirmation (WC) on PharmaCompass.

Carvedilol Phosphate Hemihydrate NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Carvedilol Phosphate Hemihydrate as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Carvedilol Phosphate Hemihydrate API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Carvedilol Phosphate Hemihydrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Carvedilol Phosphate Hemihydrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Carvedilol Phosphate Hemihydrate NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Carvedilol Phosphate Hemihydrate suppliers with NDC on PharmaCompass.

Carvedilol Phosphate Hemihydrate GMP

Carvedilol Phosphate Hemihydrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Carvedilol Phosphate Hemihydrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Carvedilol Phosphate Hemihydrate GMP manufacturer or Carvedilol Phosphate Hemihydrate GMP API supplier for your needs.

Carvedilol Phosphate Hemihydrate CoA

A Carvedilol Phosphate Hemihydrate CoA (Certificate of Analysis) is a formal document that attests to Carvedilol Phosphate Hemihydrate's compliance with Carvedilol Phosphate Hemihydrate specifications and serves as a tool for batch-level quality control.

Carvedilol Phosphate Hemihydrate CoA mostly includes findings from lab analyses of a specific batch. For each Carvedilol Phosphate Hemihydrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Carvedilol Phosphate Hemihydrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Carvedilol Phosphate Hemihydrate EP), Carvedilol Phosphate Hemihydrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Carvedilol Phosphate Hemihydrate USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty